Dyslipidemia in Chronic Kidney Disease

被引:0
作者
Sainani, Pardeep [1 ]
Das, Bhagwan [2 ]
Kumar, Santosh [1 ]
Junejo, Abdul Manan [1 ]
Memon, Rafia [2 ]
Bai, Sapna [1 ]
机构
[1] Jinnah Postgrad Med Ctr, Dept Nephrol, Karachi, Pakistan
[2] Liaquat Univ Med & Hlth Sci, Dept Nephrol, Jamshoro, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 09期
关键词
Dyslipidemia; Chronic kidney disease (CKD); Cholesterol; Low density lipoprotein (LDL); High density lipoprotein (HDL); Hypertriglyceridemia; LIPID NEPHROTOXICITY; RENAL DYSFUNCTION; CHOLESTEROL; RISK; PROGRESSION; DIET;
D O I
10.53350/pjmhs211592541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the frequency for pattern of dyslipidemia in patients with chronic kidney disease. Study Design: Descriptive, cross-sectional Place and Duration of Study: Department of Nephrology, Jinnah Postgraduate Medical Centre (JPMC) from 26th December 2018to 28th June 2019. Methodology: One hundred and thirty-two patients were enrolled. Blood sample of 5 ml of each patient was taken and sent to the institutional pathology laboratory for measurement of lipid profile and pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL, hypertriglyceridemia was noted. Results: The mean age was 44.68 +/- 9.39 years and mean of duration of chronic kidney disease was 5.13 +/- 2.19 months. Seventy eight (59%) were males and 54 (41%) were females. Pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL and hypertriglyceridemia were documented in 89 (67.4%), 61 (46.2%), 65 (49.2%) and 37 (28.0%) patients respectively. Conclusion: Dyslipidemia is common among patients with chronic kidney disease is considerable. Regular evaluation of all chronic kidney disease patients for dyslipidemia and treatment need to be instituted.
引用
收藏
页码:2541 / 2543
页数:3
相关论文
共 50 条
[31]   Potential Benefit of Statin Therapy for Dyslipidemia with Chronic Kidney Disease: Fluvastatin Renal Evaluation Trial (FRET) [J].
Inoue, Teruo ;
Ikeda, Hideo ;
Nakamura, Tsukasa ;
Abe, Shichiro ;
Taguchi, Isao ;
Kikuchi, Migaku ;
Toyoda, Shigeru ;
Miyazono, Motoaki ;
Kishi, Tomoya ;
Sanai, Toru ;
Node, Koichi .
INTERNAL MEDICINE, 2011, 50 (12) :1273-1278
[32]   Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia [J].
Ohsawa, Masato ;
Tamura, Kouichi ;
Wakui, Hiromichi ;
Kanaoka, Tomohiko ;
Azushima, Kengo ;
Uneda, Kazushi ;
Haku, Sona ;
Kobayashi, Ryu ;
Ohki, Kohji ;
Haruhara, Kotaro ;
Kinguchi, Sho ;
Toya, Yoshiyuki ;
Umemura, Satoshi .
LIPIDS IN HEALTH AND DISEASE, 2015, 14
[33]   Association of Obesity, Visceral Fat Accumulation, and Dyslipidemia with the Risk of Chronic Kidney Disease [J].
Yoshida, Yui ;
Hagiwara, Yasuhiro ;
Ito, Mari ;
Nishi, Hiroshi ;
Matsuyama, Yutaka .
INTERNAL MEDICINE, 2025,
[34]   Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease [J].
Peev, Vasil ;
Nayer, Ali ;
Contreras, Gabriel .
CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (01) :54-60
[35]   Dyslipidemia in Chronic Liver Disease [J].
Mehboob, Fatima ;
Ranjha, F. A. .
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2007, 1 (03) :103-105
[36]   Clinical assessment and management of dyslipidemia in patients with chronic kidney disease [J].
Nitta, Kosaku .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (04) :522-529
[37]   Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins [J].
Roberto Scarpioni ;
Marco Ricardi ;
Vittorio Albertazzi ;
Luigi Melfa .
World Journal of Nephrology, 2012, (06) :184-194
[38]   Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease [J].
Omran, Jad ;
Al-Dadah, Ashraf ;
Dellsperger, Kevin C. .
CARDIORENAL MEDICINE, 2013, 3 (03) :165-177
[39]   A Trial of Pitavastatin Versus Rosuvastatin for Dyslipidemia in Chronic Kidney Disease [J].
Abe, Masanori ;
Maruyama, Noriaki ;
Maruyama, Takashi ;
Okada, Kazuyoshi ;
Soma, Masayoshi .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (12) :1235-1247
[40]   Clinical assessment and management of dyslipidemia in patients with chronic kidney disease [J].
Kosaku Nitta .
Clinical and Experimental Nephrology, 2012, 16 :522-529